BR112013000481A2 - molécula de ácido nucléico de filamento simples para controle da expressão genética - Google Patents

molécula de ácido nucléico de filamento simples para controle da expressão genética

Info

Publication number
BR112013000481A2
BR112013000481A2 BR112013000481-9A BR112013000481A BR112013000481A2 BR 112013000481 A2 BR112013000481 A2 BR 112013000481A2 BR 112013000481 A BR112013000481 A BR 112013000481A BR 112013000481 A2 BR112013000481 A2 BR 112013000481A2
Authority
BR
Brazil
Prior art keywords
region
nucleic acid
acid molecule
stranded nucleic
expression
Prior art date
Application number
BR112013000481-9A
Other languages
English (en)
Japanese (ja)
Portuguese (pt)
Inventor
Ohgi Tadaaki
Shirohzu Hisao
Hamasaki Tomohiro
Itoh Akihiro
Suzuki Hiroshi
Hayashi Hirotake
Original Assignee
Bonac Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonac Corporation filed Critical Bonac Corporation
Publication of BR112013000481A2 publication Critical patent/BR112013000481A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering nucleic acids [NA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/318Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed
    • C12N2310/531Stem-loop; Hairpin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed
    • C12N2310/533Physical structure partially self-complementary or closed having a mismatch or nick in at least one of the strands

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112013000481-9A 2010-07-08 2011-07-08 molécula de ácido nucléico de filamento simples para controle da expressão genética BR112013000481A2 (pt)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
JP2010-156122 2010-07-08
JP2010156122 2010-07-08
JP2010-174915 2010-08-03
JP2010174915 2010-08-03
JP2010230806 2010-10-13
JP2010-230808 2010-10-13
JP2010230808 2010-10-13
JP2010-230806 2010-10-13
JP2010-269823 2010-12-02
US2010-269824 2010-12-02
JP2010269823 2010-12-02
JP2010269824 2010-12-02
PCT/JP2011/065737 WO2012005368A1 (ja) 2010-07-08 2011-07-08 遺伝子発現制御のための一本鎖核酸分子

Publications (1)

Publication Number Publication Date
BR112013000481A2 true BR112013000481A2 (pt) 2019-10-15

Family

ID=45441339

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013000481-9A BR112013000481A2 (pt) 2010-07-08 2011-07-08 molécula de ácido nucléico de filamento simples para controle da expressão genética

Country Status (17)

Country Link
EP (2) EP2431466B1 (enExample)
JP (3) JP4968811B2 (enExample)
KR (1) KR101849798B1 (enExample)
CN (2) CN104818276B (enExample)
AU (1) AU2011274854B2 (enExample)
BR (1) BR112013000481A2 (enExample)
CA (1) CA2804511C (enExample)
DK (2) DK2933333T3 (enExample)
ES (2) ES2670017T3 (enExample)
HU (2) HUE037500T2 (enExample)
MX (1) MX352568B (enExample)
NZ (2) NZ704812A (enExample)
PT (2) PT2933333T (enExample)
RU (1) RU2628311C2 (enExample)
SG (2) SG186899A1 (enExample)
TW (2) TWI573870B (enExample)
WO (1) WO2012005368A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691782B2 (en) 2010-08-03 2014-04-08 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
WO2013077446A1 (ja) * 2011-11-26 2013-05-30 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
WO2013133393A1 (ja) * 2012-03-07 2013-09-12 学校法人東京医科大学 Vegf遺伝子の発現抑制用一本鎖核酸分子
US20150105442A1 (en) * 2012-03-29 2015-04-16 Aqua Therapeutics Co., Ltd. Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid Molecule
CN109810977A (zh) 2012-05-26 2019-05-28 株式会社博纳克 具有递送功能的基因表达调控用单链核酸分子
EP3088524A4 (en) 2013-12-26 2017-08-09 Tokyo Medical University Artificial mimic mirna for controlling gene expression, and use of same
CA2935022A1 (en) 2013-12-27 2015-07-02 Bonac Corporation Artificial match-type mirna for controlling gene expression and use therefor
US10337009B2 (en) 2014-12-15 2019-07-02 Bonac Corporation Single-stranded nucleic acid molecule for inhibiting TGF-β1 expression
AU2015368293B2 (en) 2014-12-27 2021-07-22 Bonac Corporation Naturally occuring miRNA for controlling gene expression, and use of same
EP3276003B1 (en) 2015-03-27 2022-07-20 Bonac Corporation Single-chain nucleic acid molecule having delivery function and gene expression control ability
AU2016346703B2 (en) 2015-10-30 2020-07-02 Hirofumi Takeuchi Composition stably containing single-stranded nucleic acid molecule that suppresses expression of TGF-β1 gene
HK1259060A1 (en) * 2015-12-29 2019-11-22 国立大学法人北海道大学 Single-stranded nucleic acid molecule inhibiting expression of prorenin gene or prorenin receptor gene, and use thereof
JP6800171B2 (ja) 2016-01-30 2020-12-16 株式会社ボナック 人工単一ガイドrna及びその用途
JPWO2018182008A1 (ja) 2017-03-31 2020-02-06 株式会社ボナック 遺伝子発現制御機能を有する環状型核酸分子
JPWO2018199338A1 (ja) * 2017-04-27 2020-03-12 国立大学法人広島大学 B型肝炎治療用核酸分子
AU2018307897B2 (en) 2017-07-28 2024-01-25 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent for fibrosis
WO2019051563A1 (en) 2017-09-15 2019-03-21 Commonwealth Scientific And Industrial Research Organisation Rna molecules
JP7208911B2 (ja) 2017-10-11 2023-01-19 日東電工株式会社 核酸分子発現の調節
JPWO2019074110A1 (ja) * 2017-10-13 2020-12-24 株式会社ボナック 一本鎖核酸分子およびその製造方法
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
US20210115485A1 (en) * 2018-03-30 2021-04-22 Sumitomo Chemical Company, Limited Method for producing single-strand rna
RU2020130258A (ru) 2018-03-30 2022-05-04 Торэй Индастриз, Инк. Способ получения шпилечной одноцепочечной молекулы рнк
ES2981806T3 (es) 2018-10-02 2024-10-10 Toray Industries Método para producir moléculas de ARN monocatenario en horquilla
EP3915567A4 (en) 2019-01-25 2022-09-21 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent for fibrosis
EP4043473A4 (en) 2019-10-11 2024-03-27 Sumitomo Chemical Company, Limited Method for producing nucleic acid oligomers
CN115003680B (zh) 2020-01-29 2025-01-28 住友化学株式会社 制备核酸寡聚物的方法
JP7777452B2 (ja) 2020-01-29 2025-11-28 住友化学株式会社 核酸オリゴマーの製造方法
JP7613130B2 (ja) 2020-03-25 2025-01-15 味の素株式会社 リガーゼ変異体
KR20220160010A (ko) 2020-03-27 2022-12-05 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
KR20230034969A (ko) 2020-07-09 2023-03-10 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
KR20230074205A (ko) 2020-09-24 2023-05-26 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
EP4410770A1 (en) 2021-09-28 2024-08-07 Sumitomo Chemical Company, Limited Production method for purified dichloroacetic acid
JPWO2023182274A1 (enExample) 2022-03-23 2023-09-28
JP7201190B1 (ja) 2022-06-03 2023-01-10 株式会社セツロテック 遺伝子改変動物由来の動物繊維
EP4477659A4 (en) 2022-10-27 2025-07-30 Sumitomo Chemical Co METHOD FOR PRODUCING AN OLIGONUCLEOTIDE

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US5631148A (en) * 1994-04-22 1997-05-20 Chiron Corporation Ribozymes with product ejection by strand displacement
US6509323B1 (en) 1998-07-01 2003-01-21 California Institute Of Technology Linear cyclodextrin copolymers
FR2790757B1 (fr) * 1999-03-09 2003-08-01 Bioalliance Pharma Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant.
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
AU2003219900A1 (en) * 2002-02-22 2003-09-09 James R. Eshleman Antigene locks and therapeutic uses thereof
DK1527176T4 (en) * 2002-08-05 2017-07-03 Silence Therapeutics Gmbh ADDITIONAL NEW FORMS OF INTERFERRING RNA MOLECULES
US20040058886A1 (en) * 2002-08-08 2004-03-25 Dharmacon, Inc. Short interfering RNAs having a hairpin structure containing a non-nucleotide loop
ATE532865T1 (de) * 2003-09-30 2011-11-15 Anges Mg Inc Klammerartiges oligonukleotid und dieses enthaltender arzneistoff
EP1789553B1 (en) * 2004-06-30 2014-03-26 Alnylam Pharmaceuticals Inc. Oligonucleotides comprising a non-phosphate backbone linkage
BRPI0519690A2 (pt) * 2004-12-30 2009-03-03 Todd M Hauser composiÇÕes e mÉtodos para modular a expressço de genes usando oligonucleotÍdeos autoprotegidos
WO2007108621A1 (en) * 2006-03-17 2007-09-27 Bioneer Corporation Sirna for inhibiting nf-kb/rela expression
JP5296328B2 (ja) * 2007-05-09 2013-09-25 独立行政法人理化学研究所 1本鎖環状rnaおよびその製造方法
JP2011504730A (ja) * 2007-11-29 2011-02-17 蘇州瑞博生物技術有限公司 標的遺伝子の発現を干渉する複合体分子およびその合成方法
US20110159586A1 (en) * 2007-12-07 2011-06-30 Halo-Bio Rnai Therapeutics, Inc. Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides
EP2256191A4 (en) * 2008-02-15 2011-07-06 Riken CYCLIC SINGLE NUCLEIC ACID COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
JP5187580B2 (ja) 2008-12-26 2013-04-24 丸紅建材リース株式会社 掘削機の泥土飛散防止装置
JP2010174915A (ja) 2009-01-27 2010-08-12 Toyota Motor Corp 高圧ガスタンク
JP5449815B2 (ja) 2009-03-26 2014-03-19 住友化学株式会社 偏光板の製造方法
JP5233790B2 (ja) 2009-03-26 2013-07-10 船井電機株式会社 液晶モジュール
JP4885255B2 (ja) 2009-05-21 2012-02-29 株式会社エフピコ 包装用容器
JP2010269823A (ja) 2009-05-21 2010-12-02 British American Tobacco Japan Kk 喫煙品用容器

Also Published As

Publication number Publication date
CN102918156A (zh) 2013-02-06
CA2804511A1 (en) 2012-01-12
CA2804511C (en) 2021-07-06
TWI573870B (zh) 2017-03-11
JP2012130342A (ja) 2012-07-12
TW201217523A (en) 2012-05-01
WO2012005368A1 (ja) 2012-01-12
AU2011274854A1 (en) 2013-02-14
TWI527901B (zh) 2016-04-01
NZ606232A (en) 2015-06-26
PT2933333T (pt) 2018-04-24
EP2431466A4 (en) 2012-04-25
HK1181423A1 (zh) 2013-11-08
EP2933333B1 (en) 2018-02-21
CN102918156B (zh) 2015-11-25
EP2933333A1 (en) 2015-10-21
SG186899A1 (en) 2013-02-28
MX352568B (es) 2017-11-29
DK2933333T3 (en) 2018-04-30
JP4968811B2 (ja) 2012-07-04
MX2013000315A (es) 2013-05-01
HUE026520T2 (en) 2016-06-28
KR101849798B1 (ko) 2018-04-17
JPWO2012005368A1 (ja) 2013-09-05
HUE037500T2 (hu) 2018-08-28
CN104818276A (zh) 2015-08-05
EP2431466B1 (en) 2015-10-07
JP6162182B2 (ja) 2017-07-12
RU2628311C2 (ru) 2017-08-15
PT2431466E (pt) 2016-01-08
TW201627500A (zh) 2016-08-01
ES2550487T3 (es) 2015-11-10
RU2013105329A (ru) 2014-08-20
CN104818276B (zh) 2020-12-11
DK2431466T3 (en) 2016-01-11
NZ704812A (en) 2017-01-27
KR20130090792A (ko) 2013-08-14
AU2011274854B2 (en) 2015-04-16
ES2670017T3 (es) 2018-05-29
SG196779A1 (en) 2014-02-13
JP2015231381A (ja) 2015-12-24
JP5804642B2 (ja) 2015-11-04
EP2431466A1 (en) 2012-03-21

Similar Documents

Publication Publication Date Title
BR112013000481A2 (pt) molécula de ácido nucléico de filamento simples para controle da expressão genética
BR122022007092B8 (pt) Método para construir um perfil de dna, método para construir uma biblioteca de ácido nucléico, biblioteca de ácido nucléico, pluralidade de iniciadores e kit
BR112012030711A2 (pt) derivado de purinona
EP4357457A3 (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
MX2017006670A (es) Metodos y composiciones para la modificacion genetica dirigida mediante el uso de arn guia combinados.
MX390699B (es) Composiciones y metodos para inhibicion de genes para apolipoproteina c-iii (apoc3).
CO2017007335A2 (es) Supresión del gen de la huntingtina inducida por la arni
BR112018075479A2 (pt) portadores híbridos para carga de ácido nucleico
BR112015000710A8 (pt) Oligonucleotídeos para fazer uma alteração na sequência de um presente alvo de molécula de rna em uma célula viva
SA523441205B1 (ar) التحرير المتعدد للجينوم
BR112012025872A2 (pt) primidinas modificadas na posição-5 e seu uso
BR112017008291A2 (pt) oligonucleotídeos para edição de dna genômico
BR112012026644A2 (pt) compostos antivirais
MX385330B (es) Regulación transcripcional guiada por ácido ribonucleico.
MX382223B (es) Regulacion de expresion genica mediada por nucleasa.
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
AR090869A1 (es) COMPOSICIONES DE ARNi DE SERPINC1 Y SUS METODOS DE USO
UA116206C2 (uk) Спосіб боротьби з кліщами varroa destructor у бджіл
BR112012026641A2 (pt) compostos antivirais
EA201291024A1 (ru) Композиции эндорибонуклеаз и способы их использования
BR112017017525A2 (pt) produção de fdca catalisada por desidrogenase
JP2016528887A5 (enExample)
BR112015013415A2 (pt) detergente para lavagem de louça
BR112013028022A2 (pt) unidade de barras de turbulência, cilindro de secagem, e, método para instalar uma unidade de barra de turbulência no interior de um cilindro
BR112015016495A8 (pt) Composições, complexo de ácidos nucleicos e célula e meio não transitório legível por computador

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: BONAC CORPORATION (JP)

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO 870230104355 DE28/11/2023 E NECESSARIO APRESENTAR TRADUCAO JURAMENTADA DOS DOCUMENTOS APRESENTADOS QUENAO ESTIVEREM EM PORTUGUES.

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: TORAY INDUSTRIES INC. (JP)

Free format text: ANULADA A PUBLICACAO CODIGO 25.3 NA RPI NO 2762 DE 12/12/2023 POR TER SIDO INDEVIDA.

B25A Requested transfer of rights approved

Owner name: TORAY INDUSTRIES INC. (JP)